1. Stocks
  2. Concord Drugs Ltd.
  3. Swot
swot-logo

Concord Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Concord Drugs Ltd. has 17 Strengths, 9 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing profits every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Volume Shockers

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)